DAWN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,688,629.99

Day One Biopharmaceuticals Insider Trading History Chart

Day One Biopharmaceuticals Share Price & Price History

^$12.79

▲ +0.33 (2.65%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

WARNING: “Buffett Indicator” flashing for first time in 50 years

From Behind the Markets | Ad

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Day One Biopharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/10/2024	Samuel C. Blackman	Insider	Sell	30,000	$13.31	$399,300.00	1,034,015
11/11/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.10	$161,000.00	1,057,535
11/7/2024	Samuel C. Blackman	Insider	Sell	11,245	$16.03	$180,257.35	1,085,790
10/31/2024	Samuel C. Blackman	Insider	Sell	500	$16.02	$8,010.00	1,097,035
9/10/2024	Samuel C. Blackman	Insider	Sell	30,000	$14.22	$426,600.00	1,097,535
8/16/2024	Adam Dubow	General Counsel	Sell	3,202	$14.00	$44,828.00	26,928
8/16/2024	Charles N York II	CFO	Sell	2,633	$14.00	$36,862.00	232,485
8/16/2024	Jeremy Bender	CEO	Sell	10,681	$14.00	$149,534.00	98,932
8/16/2024	Samuel C. Blackman	Insider	Sell	2,232	$14.00	$31,248.00	1,127,535
7/16/2024	Samuel C. Blackman	Insider	Sell	20,000	$16.01	$320,200.00	1,121,081
6/21/2024	Saira Ramasastry	Director	Sell	10,000	$13.19	$131,900.00	40,485
5/16/2024	Adam Dubow	General Counsel	Sell	3,253	$16.08	$52,308.24	21,731
5/16/2024	Charles N York II	CFO	Sell	2,675	$16.08	$43,014.00	224,868
5/16/2024	Jeremy Bender	CEO	Sell	7,873	$16.08	$126,597.84	654,728
5/16/2024	Samuel C. Blackman	Insider	Sell	2,267	$16.08	$36,453.36	1,171,081
5/10/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.37	$163,700.00	1,164,662
5/3/2024	Charles N York II	CFO	Sell	8,078	$17.85	$144,192.30	217,293
5/3/2024	Jeremy Bender	CEO	Sell	9,154	$17.85	$163,398.90	642,602
5/1/2024	Charles N York II	CFO	Sell	52,183	$17.89	$933,553.87	225,571
5/1/2024	Jeremy Bender	CEO	Sell	70,051	$17.88	$1,252,511.88	651,762
4/18/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.02	$160,200.00	1,174,662
3/25/2024	Samuel C. Blackman	Insider	Sell	10,000	$16.01	$160,100.00	1,184,662
2/27/2024	Samuel C. Blackman	Insider	Sell	20,000	$16.11	$322,200.00	1,224,662
2/16/2024	Adam Dubow	General Counsel	Sell	3,242	$15.25	$49,440.50	16,585
2/16/2024	Charles N York II	CFO	Sell	2,666	$15.25	$40,656.50	277,754
2/16/2024	Jeremy Bender	CEO	Sell	7,615	$15.25	$116,128.75	721,813
2/16/2024	Samuel C. Blackman	Insider	Sell	2,258	$15.25	$34,434.50	1,244,662
11/16/2023	Adam Dubow	General Counsel	Sell	5,313	$11.69	$62,108.97	11,428
11/16/2023	Charles N York II	CFO	Sell	956	$11.69	$11,175.64	270,170
11/16/2023	Jeremy Bender	CEO	Sell	3,107	$11.69	$36,320.83	709,429
11/16/2023	Samuel C. Blackman	Insider	Sell	709	$11.69	$8,288.21	1,238,234
10/19/2023	Ai Day1 Llc	Major Shareholder	Buy	384,400	$10.06	$3,867,064.00	12,817,935
8/17/2023	Charles N York II	CFO	Sell	922	$13.86	$12,778.92	267,501
8/17/2023	Jeremy Bender	CEO	Sell	2,996	$13.86	$41,524.56	704,224
8/17/2023	Samuel C. Blackman	Insider	Sell	668	$13.86	$9,258.48	1,236,319
6/9/2023	Ai Day1 Llc	Major Shareholder	Buy	769,230	$13.00	$9,999,990.00	11,453,868
6/5/2023	Samuel C. Blackman	Insider	Sell	1,229	$16.00	$19,664.00	1,234,363
5/16/2023	Charles N York II	CFO	Sell	955	$13.12	$12,529.60	264,798
5/16/2023	Jeremy Bender	CEO	Sell	3,104	$13.12	$40,724.48	1,179,484
5/16/2023	Samuel C. Blackman	Insider	Sell	692	$13.12	$9,079.04	1,235,592
3/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$18.05	$180,500.00	1,233,660
3/7/2023	Jeremy Bender	CEO	Sell	12,500	$20.01	$250,125.00	1,174,276
2/16/2023	Charles N York II	CFO	Sell	930	$19.57	$18,200.10	271,505
2/16/2023	Jeremy Bender	CEO	Sell	3,022	$19.57	$59,140.54	1,186,776
2/16/2023	Samuel C. Blackman	Insider	Sell	674	$19.57	$13,190.18	1,243,660
2/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$20.07	$200,700.00	1,241,710
1/23/2023	Jeremy Bender	CEO	Sell	12,500	$22.00	$275,000.00	1,181,486
1/20/2023	Charles N York II	CFO	Sell	10,000	$22.75	$227,500.00	268,810
1/10/2023	Samuel C. Blackman	Insider	Sell	10,000	$22.86	$228,600.00	1,250,148
1/3/2023	Julie Papanek Grant	Director	Sell	25,000	$20.65	$516,250.00	380,000
12/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.32	$254,000.00	1,192,424
12/20/2022	Charles N York II	CFO	Sell	10,000	$20.07	$200,700.00	276,497
12/8/2022	Julie Papanek Grant	Director	Sell	4,358	$22.08	$96,224.64	405,000
12/1/2022	Julie Papanek Grant	Director	Sell	5,000	$21.75	$108,750.00	414,358
12/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$21.45	$214,500.00	1,260,148
11/21/2022	Charles N York II	CFO	Sell	10,000	$20.76	$207,600.00	286,497
11/21/2022	Jeremy Bender	CEO	Sell	12,500	$20.76	$259,500.00	1,204,924
11/16/2022	Charles N York II	CFO	Sell	430	$21.46	$9,227.80	296,497
11/16/2022	Jeremy Bender	CEO	Sell	1,513	$21.46	$32,468.98	1,217,424
11/16/2022	Samuel C. Blackman	Insider	Sell	377	$21.46	$8,090.42	1,270,148
11/1/2022	Charles N York II	CFO	Sell	10,000	$20.03	$200,300.00	294,401
11/1/2022	Jeremy Bender	CEO	Sell	12,500	$20.03	$250,375.00	1,215,375
11/1/2022	Julie Papanek Grant	Director	Sell	5,000	$20.04	$100,200.00	424,358
10/3/2022	Charles N York II	CFO	Sell	10,000	$20.05	$200,500.00	304,401
10/3/2022	Jeremy Bender	CEO	Sell	12,500	$20.05	$250,625.00	1,227,875
10/3/2022	Julie Papanek Grant	Director	Sell	5,000	$20.06	$100,300.00	434,358
9/21/2022	Julie Papanek Grant	Director	Sell	613,603	$18.55	$11,382,335.65	8,464,301
9/20/2022	Xi L.P. Canaan	Major Shareholder	Sell	148,670	$19.51	$2,900,551.70	9,077,904
9/19/2022	Julie Papanek Grant	Director	Sell	76,725	$20.57	$1,578,233.25	9,226,574
9/16/2022	Xi L.P. Canaan	Major Shareholder	Sell	115,307	$21.55	$2,484,865.85	9,303,299
9/15/2022	Julie Papanek Grant	Director	Sell	51,281	$22.85	$1,171,770.85	9,418,606
9/14/2022	Xi L.P. Canaan	Major Shareholder	Sell	106,111	$23.68	$2,512,708.48	9,469,887
9/13/2022	Julie Papanek Grant	Director	Sell	87,647	$24.40	$2,138,586.80	9,575,998
9/2/2022	Papanek Julie Grant	Director	Sell	5,000	$23.82	$119,100.00	439,358
8/16/2022	Charles N York II	CFO	Sell	1,089	$24.31	$26,473.59	324,401
8/16/2022	Jeremy Bender	CEO	Sell	4,003	$24.31	$97,312.93	1,252,875
8/16/2022	Samuel C. Blackman	Insider	Sell	941	$24.31	$22,875.71	1,299,338
8/4/2022	Charles N York II	CFO	Sell	10,000	$20.05	$200,500.00	321,365
8/4/2022	Jeremy Bender	CEO	Sell	12,500	$20.00	$250,000.00	1,246,192
8/4/2022	Papanek Julie Grant	Director	Sell	5,000	$20.00	$100,000.00	454,358
8/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$16.88	$168,800.00	1,296,718
7/18/2022	Charles N York II	CFO	Sell	2,500	$20.00	$50,000.00	331,365
7/18/2022	Papanek Julie Grant	Director	Sell	2,600	$20.00	$52,000.00	459,358
7/8/2022	Charles N York II	CFO	Sell	1,416	$20.00	$28,320.00	333,865
7/8/2022	Jeremy Bender	CEO	Sell	1,795	$20.00	$35,900.00	1,261,292
7/8/2022	Papanek Julie Grant	Director	Sell	1,242	$20.00	$24,840.00	461,958
7/5/2022	Charles N York II	CFO	Sell	800	$20.00	$16,000.00	335,281
7/5/2022	Jeremy Bender	CEO	Sell	857	$20.00	$17,140.00	1,263,087
7/1/2022	Charles N York II	CFO	Sell	1,479	$20.00	$29,580.00	336,081
7/1/2022	Jeremy Bender	CEO	Sell	1,746	$20.00	$34,920.00	1,263,944
7/1/2022	Papanek Julie Grant	Director	Sell	1,000	$20.00	$20,000.00	464,000
7/1/2022	Samuel C. Blackman	Insider	Sell	10,000	$18.72	$187,200.00	1,306,718
6/17/2022	Ai Day1 Llc	Major Shareholder	Buy	1,200,000	$15.00	$18,000,000.00	10,684,638
6/17/2022	Michael Gladstone	Director	Buy	766,667	$15.00	$11,500,005.00	766,667
6/15/2022	Samuel C. Blackman	Insider	Sell	50,000	$16.26	$813,000.00	1,316,718
1/20/2022	Ai Day1 Llc	Major Shareholder	Buy	4,615	$14.73	$67,978.95
1/18/2022	Ai Day1 Llc	Major Shareholder	Buy	43,429	$14.26	$619,297.54
1/3/2022	Samuel C. Blackman	Insider	Sell	10,000	$17.10	$171,000.00

AI breakthrough about to upend industry

From Porter & Company | Ad

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

I urge you to watch it now.

SEC Filings (Institutional Ownership Changes) for Day One Biopharmaceuticals (NASDAQ:DAWN)

87.95% of Day One Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Day One Biopharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/27/2024	Franklin Resources Inc.	3,869,632	$55.34M	0.0%	+2.3%	3.837%
11/16/2024	Geode Capital Management LLC	1,432,697	$19.96M	0.0%	+10.5%	1.421%
11/15/2024	Frazier Life Sciences Management L.P.	689,655	$9.61M	0.4%	N/A	0.684%
11/15/2024	XTX Topco Ltd	12,778	$0.18M	0.0%	N/A	0.013%
11/15/2024	Wellington Management Group LLP	721,581	$10.05M	0.0%	+142.1%	0.716%
11/15/2024	State Street Corp	2,823,817	$39.34M	0.0%	-0.1%	2.800%
11/15/2024	Samsara BioCapital LLC	147,319	$2.05M	0.4%	-25.0%	0.146%
11/15/2024	Parkman Healthcare Partners LLC	924,140	$12.87M	1.6%	+1.7%	0.916%
11/15/2024	Janus Henderson Group PLC	2,177,197	$30.31M	0.0%	+18.4%	2.159%
11/15/2024	Erste Asset Management GmbH	51,200	$0.73M	0.0%	N/A	0.051%
11/14/2024	Maverick Capital Ltd.	2,114,006	$29.45M	0.6%	+74.5%	2.096%
11/14/2024	PFM Health Sciences LP	342,172	$4.77M	0.3%	-13.7%	0.339%
11/14/2024	Braidwell LP	4,873,853	$67.89M	1.9%	+60.5%	4.833%
11/14/2024	Verition Fund Management LLC	31,075	$0.43M	0.0%	+31.4%	0.031%
11/14/2024	Vestal Point Capital LP	2,500,000	$34.83M	2.6%	+100.0%	2.479%
11/14/2024	Walleye Capital LLC	34,266	$0.48M	0.0%	N/A	0.034%
11/14/2024	Martingale Asset Management L P	71,304	$0.99M	0.0%	+9.6%	0.071%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	65,193	$0.91M	0.0%	-6.5%	0.065%
11/14/2024	Stonepine Capital Management LLC	205,675	$2.87M	1.8%	N/A	0.204%
11/13/2024	FMR LLC	7,412,380	$103.25M	0.0%	+178.5%	7.350%
11/13/2024	Dynamic Technology Lab Private Ltd	12,474	$0.17M	0.0%	N/A	0.012%
11/12/2024	Algert Global LLC	71,487	$1M	0.0%	+248.8%	0.071%
11/12/2024	Charles Schwab Investment Management Inc.	507,448	$7.07M	0.0%	+14.6%	0.503%
11/9/2024	Intech Investment Management LLC	23,236	$0.32M	0.0%	N/A	0.023%
11/7/2024	First Turn Management LLC	947,878	$13.20M	2.1%	N/A	0.940%
11/7/2024	Quest Partners LLC	7,751	$0.11M	0.0%	+9,238.6%	0.008%
11/5/2024	GSA Capital Partners LLP	59,259	$0.83M	0.1%	N/A	0.059%
11/4/2024	TimesSquare Capital Management LLC	1,827,695	$25.46M	0.4%	+8.2%	1.812%
10/25/2024	SteelPeak Wealth LLC	17,400	$0.24M	0.0%	+9.8%	0.020%
10/25/2024	China Universal Asset Management Co. Ltd.	19,203	$0.27M	0.0%	+87.0%	0.022%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	3,611	$51K	0.0%	+38.4%	0.004%
10/23/2024	Hennion & Walsh Asset Management Inc.	63,566	$0.89M	0.0%	-1.2%	0.073%
10/10/2024	Essex Investment Management Co. LLC	184,230	$2.57M	0.4%	N/A	0.211%
10/10/2024	Exchange Traded Concepts LLC	12,286	$0.17M	0.0%	-19.8%	0.014%
10/5/2024	Handelsbanken Fonder AB	27,000	$0.38M	0.0%	+16.9%	0.031%
9/16/2024	Point72 DIFC Ltd	8,992	$0.12M	0.0%	N/A	0.010%
8/21/2024	Regency Capital Management Inc. DE	10,000	$0.14M	0.1%	-9.1%	0.011%
8/19/2024	Point72 Asset Management L.P.	470,247	$6.48M	0.0%	N/A	0.538%
8/16/2024	Algert Global LLC	20,497	$0.28M	0.0%	-18.1%	0.023%
8/16/2024	Driehaus Capital Management LLC	706,446	$9.74M	0.1%	-1.7%	0.808%
8/15/2024	The Manufacturers Life Insurance Company	48,274	$0.67M	0.0%	-4.2%	0.055%
8/15/2024	Maverick Capital Ltd.	1,211,138	$16.69M	0.3%	-3.6%	1.386%
8/15/2024	Deerfield Management Company L.P. Series C	2,923,137	$40.28M	0.7%	+65.6%	3.345%
8/15/2024	AQR Capital Management LLC	113,020	$1.56M	0.0%	+517.0%	0.129%
8/14/2024	Squarepoint Ops LLC	186,484	$2.57M	0.0%	N/A	0.213%
8/14/2024	Point72 DIFC Ltd	8,992	$0.12M	0.0%	N/A	0.010%
8/14/2024	Marshall Wace LLP	161,129	$2.22M	0.0%	+20.1%	0.184%
8/14/2024	Ally Bridge Group NY LLC	536,095	$7.39M	4.4%	N/A	0.613%
8/14/2024	ProShare Advisors LLC	13,787	$0.19M	0.0%	-20.7%	0.016%
8/14/2024	Profund Advisors LLC	27,607	$0.38M	0.0%	-9.8%	0.032%
8/12/2024	Hsbc Holdings PLC	11,658	$0.16M	0.0%	N/A	0.013%
8/9/2024	Renaissance Technologies LLC	72,140	$0.99M	0.0%	N/A	0.083%
8/9/2024	Dimensional Fund Advisors LP	888,117	$12.24M	0.0%	-9.5%	1.016%
8/1/2024	Rhumbline Advisers	85,438	$1.18M	0.0%	-4.8%	0.098%
7/26/2024	Bank of New York Mellon Corp	208,396	$2.87M	0.0%	-3.2%	0.238%
7/20/2024	Hennion & Walsh Asset Management Inc.	64,359	$0.89M	0.0%	+8.6%	0.074%
7/17/2024	SteelPeak Wealth LLC	15,850	$0.22M	0.0%	N/A	0.018%
7/12/2024	SG Americas Securities LLC	8,222	$0.11M	0.0%	N/A	0.009%
5/16/2024	California State Teachers Retirement System	49,340	$0.82M	0.0%	-6.8%	0.056%
5/16/2024	Janus Henderson Group PLC	2,032,384	$33.58M	0.0%	+19.8%	2.326%
5/16/2024	Bayesian Capital Management LP	13,374	$0.22M	0.0%	N/A	0.015%
5/15/2024	Estuary Capital Management LP	1,611,137	$26.62M	10.8%	+82.5%	1.844%
5/15/2024	Price T Rowe Associates Inc. MD	2,299,764	$37.99M	0.0%	-0.7%	2.632%
5/15/2024	Altitude Crest Partners Inc.	195,497	$3.23M	1.4%	N/A	0.224%
5/10/2024	Vanguard Group Inc.	4,774,483	$78.87M	0.0%	+0.1%	5.464%
5/9/2024	State Board of Administration of Florida Retirement System	10,650	$0.18M	0.0%	-40.4%	0.012%
5/8/2024	Summit Rock Advisors LP	51,502	$0.85M	0.3%	N/A	0.059%
5/8/2024	ProShare Advisors LLC	17,379	$0.29M	0.0%	+9.1%	0.020%
5/7/2024	Regency Capital Management Inc. DE	11,000	$0.18M	0.1%	-8.3%	0.013%
5/7/2024	TimesSquare Capital Management LLC	1,635,145	$27.01M	0.4%	-1.9%	1.871%
5/6/2024	Atlas Venture Life Science Advisors LLC	6,430,257	$106.23M	9.8%	-15.5%	7.359%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	21,863	$0.36M	0.0%	-50.4%	0.025%
4/29/2024	China Universal Asset Management Co. Ltd.	16,817	$0.28M	0.0%	+67.1%	0.019%
4/17/2024	Hennion & Walsh Asset Management Inc.	59,289	$0.98M	0.1%	+2.5%	0.068%
3/5/2024	Fisher Asset Management LLC	68,446	$1M	0.0%	+89.0%	0.078%
3/5/2024	Wellington Management Group LLP	208,969	$3.05M	0.0%	+77.7%	0.239%
3/1/2024	Goldman Sachs Group Inc.	2,118,849	$30.94M	0.0%	+28.7%	2.425%
2/29/2024	Quintet Private Bank Europe S.A.	3,313	$48K	0.0%	+43.2%	0.004%
2/20/2024	Quarry LP	5,000	$73K	0.0%	-23.3%	0.006%
2/15/2024	PFM Health Sciences LP	1,303,575	$19.03M	1.1%	-41.4%	1.498%
2/15/2024	Parkman Healthcare Partners LLC	625,749	$9.14M	1.3%	+34.2%	0.719%
2/14/2024	Braidwell LP	4,215,573	$61.55M	2.3%	+13.5%	4.843%
2/14/2024	Superstring Capital Management LP	379,626	$5.54M	4.0%	N/A	0.436%
2/13/2024	Rafferty Asset Management LLC	236,347	$3.45M	0.0%	-0.3%	0.272%
2/13/2024	NEOS Investment Management LLC	15,507	$0.23M	0.0%	N/A	0.018%
2/9/2024	Franklin Resources Inc.	4,236,795	$61.86M	0.0%	+4.2%	4.868%
2/9/2024	Quest Partners LLC	1,980	$29K	0.0%	N/A	0.002%
2/9/2024	Dynamic Technology Lab Private Ltd	10,651	$0.16M	0.0%	N/A	0.012%
2/8/2024	Nicholas Investment Partners LP	303,318	$4.43M	0.5%	-86.1%	0.348%
2/8/2024	First Turn Management LLC	1,700,949	$24.83M	3.6%	N/A	1.954%
2/7/2024	Teacher Retirement System of Texas	10,860	$0.16M	0.0%	-15.7%	0.012%
2/7/2024	TimesSquare Capital Management LLC	1,666,065	$24.33M	0.4%	+45.8%	1.914%
2/6/2024	Charles Schwab Investment Management Inc.	452,934	$6.61M	0.0%	+1.3%	0.520%
2/6/2024	Fisher Asset Management LLC	68,411	$1M	0.0%	+88.9%	0.079%
2/1/2024	New York State Common Retirement Fund	78,299	$1.14M	0.0%	+20.5%	0.090%
2/1/2024	Handelsbanken Fonder AB	17,400	$0.25M	0.0%	N/A	0.020%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	6,978	$0.10M	0.0%	-24.6%	0.008%
1/30/2024	Vontobel Holding Ltd.	15,500	$0.23M	0.0%	-34.9%	0.018%
1/24/2024	Arizona State Retirement System	13,373	$0.20M	0.0%	+8.2%	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	10,067	$0.15M	0.0%	+352.2%	0.012%

Data available starting January 2016

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Today's Range

Now: $12.79

$12.11

$13.00

50 Day Range

MA: $14.07

$12.46

$16.39

52 Week Range

Now: $12.79

$11.94

$18.07

Volume

2,277,932 shs

Average Volume

964,505 shs

Market Capitalization

$1.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top insider investors include:
Ai Day1 Llc (Major Shareholder)
Samuel C Blackman (Insider)
Jeremy Bender (CEO)
Julie Papanek Grant (Director)
Charles N York II (CFO)
Saira Ramasastry (Director)
Adam Dubow (General Counsel)
Learn More about top insider investors at Day One Biopharmaceuticals.
Who are the major institutional investors of Day One Biopharmaceuticals?: Day One Biopharmaceuticals' top institutional shareholders include:
FMR LLC — 7.35%
Braidwell LP — 4.83%
Franklin Resources Inc. — 3.84%
State Street Corp — 2.80%
Vestal Point Capital LP — 2.48%
Janus Henderson Group PLC — 2.16%
Learn More about top institutional investors of Day One Biopharmaceuticals stock.
Which major investors are selling Day One Biopharmaceuticals stock?: During the previous quarter, DAWN stock was sold by these institutional investors:
PFM Health Sciences LP
Samsara BioCapital LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Exchange Traded Concepts LLC
State Street Corp
Hennion & Walsh Asset Management Inc.
During the previous year, company insiders that have sold Day One Biopharmaceuticals company stock include:
Ai Day1 Llc (Major Shareholder)
Samuel C Blackman (Insider)
Jeremy Bender (CEO)
Julie Papanek Grant (Director)
Charles N York II (CFO)
Learn More investors selling Day One Biopharmaceuticals stock.
Which major investors are buying Day One Biopharmaceuticals stock?: Within the previous quarter, DAWN stock was acquired by institutional investors including:
FMR LLC
Braidwell LP
Vestal Point Capital LP
First Turn Management LLC
Maverick Capital Ltd.
Frazier Life Sciences Management L.P.
Wellington Management Group LLP
Janus Henderson Group PLC